Cipla
Karthik Hariharan is a finance professional with extensive experience in various roles within Cipla, including Cluster Finance Manager for Urology & CNS, and previous positions in Global FP&A. Karthik's contributions have included P&L consolidation for executive leadership, business planning, and cost optimization initiatives that resulted in significant savings. Prior experience includes an article assistant role at B.D. Jokhakar & Co, where Karthik was involved in statutory and tax audits, and management of financial records. Karthik is a qualified Chartered Accountant and has completed a BCOM in Accounting and Finance.
This person is not in any teams
This person is not in any offices
Cipla
19 followers
Cipla is a pharmaceutical company. The Company's strategic business units include Active Pharmaceutical Ingredients (APIs), Respiratory and Cipla Global Access. The Company's geographical segments include India, USA, South Africa and Rest of the World. The Company manufactures metered dose inhalers, dry powder inhalers, nasal sprays, nebulizers and a range of inhaled accessory devices. Cipla Global Access is a tender-based institutional business that concentrates on approximately four therapy areas: human immunodeficiency virus/acquired immuno deficiency syndrome (HIV/AIDS), malaria, multi drug-resistant tuberculosis and reproductive health. The Company offers its products for the therapeutic areas, including cardiovascular, children's health, dermatology and cosmetology, diabetes, HIV/AIDS, infectious diseases and critical care, malaria, neurosciences, oncology, ophthalmology, osteoporosis, respiratory, urology and women's health.